speb/financial-data huggingface dataset:
AMBR income_statement (quarterly, 2025-09-30) — +Total Revenue: 16297000.00
AMBR balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 115094000.00
AMBR balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 16461000.00
AMBR balance_sheet (quarterly, 2025-09-30) — Allowance For Doubtful Accounts Receivable: -1884000.00
AMBR balance_sheet (quarterly, 2025-09-30) — Assets Held For Sale Current: 6565000.00
AMBR income_statement (quarterly, 2025-09-30) — Basic Average Shares: 93562823.00
AMBR income_statement (quarterly, 2025-09-30) — Basic EPS: 0.02
AMBR balance_sheet (quarterly, 2025-09-30) — Capital Stock: 79714000.00
AMBR balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 39923000.00
AMBR balance_sheet (quarterly, 2025-09-30) — Common Stock: 79714000.00
AMBR balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 125156000.00
AMBR income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 4520000.00
AMBR balance_sheet (quarterly, 2025-09-30) — Current Assets: 253484000.00
AMBR balance_sheet (quarterly, 2025-09-30) — Current Debt: 2000.00
AMBR balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 2000.00
AMBR balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 200743000.00
AMBR income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 93610599.00
AMBR income_statement (quarterly, 2025-09-30) — Diluted EPS: 0.02
AMBR income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 1509000.00
AMBR balance_sheet (quarterly, 2025-09-30) — Duefrom Related Parties Current: 24915000.00
AMBR balance_sheet (quarterly, 2025-09-30) — Dueto Related Parties Current: 30002000.00
AMBR income_statement (quarterly, 2025-09-30) — EBIT: 1375000.00
AMBR income_statement (quarterly, 2025-09-30) — EBITDA: 1375000.00
AMBR income_statement (quarterly, 2025-09-30) — Earnings From Equity Interest: -14000.00
AMBR balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: 79151000.00
AMBR income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 6123000.00
AMBR balance_sheet (quarterly, 2025-09-30) — Goodwill: 65922000.00
AMBR balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 68973000.00
AMBR balance_sheet (quarterly, 2025-09-30) — Gross Accounts Receivable: 18345000.00
AMBR income_statement (quarterly, 2025-09-30) — Gross Profit: 11777000.00
AMBR balance_sheet (quarterly, 2025-09-30) — Hedging Assets Current: 90479000.00
AMBR income_statement (quarterly, 2025-09-30) — Interest Income: 260000.00
AMBR income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 260000.00
AMBR balance_sheet (quarterly, 2025-09-30) — Invested Capital: 125158000.00
AMBR balance_sheet (quarterly, 2025-09-30) — Line Of Credit: 2000.00
AMBR balance_sheet (quarterly, 2025-09-30) — Minority Interest: -1104000.00
AMBR income_statement (quarterly, 2025-09-30) — Minority Interests: 0.00
AMBR balance_sheet (quarterly, 2025-09-30) — Net Debt: 2000.00
AMBR income_statement (quarterly, 2025-09-30) — Net Income: 1509000.00
AMBR income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 1509000.00
AMBR income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 2151000.00
AMBR income_statement (quarterly, 2025-09-30) — Net Income Discontinuous Operations: -642000.00
AMBR income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 1509000.00
AMBR income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 2151000.00
AMBR income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 1509000.00
AMBR income_statement (quarterly, 2025-09-30) — Net Interest Income: 260000.00
AMBR income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: 260000.00
AMBR balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 56183000.00
AMBR income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 1375000.00
AMBR income_statement (quarterly, 2025-09-30) — Normalized Income: 2151000.00
AMBR income_statement (quarterly, 2025-09-30) — Operating Income: 1375000.00
AMBR income_statement (quarterly, 2025-09-30) — Operating Revenue: 16297000.00
AMBR balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 468414626.00
AMBR balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 55518000.00
AMBR balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 26391000.00
AMBR balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: 79151000.00
AMBR income_statement (quarterly, 2025-09-30) — Other Gand A: 6123000.00
AMBR income_statement (quarterly, 2025-09-30) — Other Income Expense: 503000.00
AMBR balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 3051000.00
AMBR balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 3303000.00
AMBR balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 965000.00
AMBR income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 517000.00
AMBR balance_sheet (quarterly, 2025-09-30) — Other Payable: 29254000.00
AMBR balance_sheet (quarterly, 2025-09-30) — Other Receivables: 19623000.00
AMBR balance_sheet (quarterly, 2025-09-30) — Payables: 174350000.00
AMBR balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 174350000.00
AMBR income_statement (quarterly, 2025-09-30) — Pretax Income: 2138000.00
AMBR balance_sheet (quarterly, 2025-09-30) — Receivables: 60999000.00
AMBR income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 4520000.00
AMBR income_statement (quarterly, 2025-09-30) — Research And Development: 1643000.00
AMBR balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -33709000.00
AMBR income_statement (quarterly, 2025-09-30) — Selling And Marketing Expense: 2636000.00
AMBR income_statement (quarterly, 2025-09-30) — Selling General And Administration: 8759000.00
AMBR balance_sheet (quarterly, 2025-09-30) — Share Issued: 468414626.00
AMBR balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 125156000.00
AMBR balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 56183000.00
AMBR income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
AMBR income_statement (quarterly, 2025-09-30) — Tax Provision: -13000.00
AMBR income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.17
AMBR balance_sheet (quarterly, 2025-09-30) — Total Assets: 325760000.00
AMBR balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 125156000.00
AMBR balance_sheet (quarterly, 2025-09-30) — Total Debt: 2000.00
AMBR balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 124052000.00
AMBR income_statement (quarterly, 2025-09-30) — Total Expenses: 14922000.00
AMBR balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 201708000.00
AMBR balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 72276000.00
AMBR balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 965000.00
AMBR income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: 1375000.00
AMBR balance_sheet (quarterly, 2025-09-30) — Working Capital: 52741000.00
AMBR income_statement (annual, 2025-12-31) — +Operating Expense: 46625000.00
AMBR income_statement (quarterly, 2025-12-31) — +Operating Expense: 10753000.00
AMBR income_statement (annual, 2025-12-31) — +Total Revenue: 66089000.00
AMBR income_statement (quarterly, 2025-12-31) — +Total Revenue: 16337000.00
AMBR balance_sheet (annual, 2025-12-31) — Accounts Payable: 3080000.00
AMBR balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 3080000.00
AMBR balance_sheet (annual, 2025-12-31) — Accounts Receivable: 5490000.00
AMBR balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 5490000.00
AMBR balance_sheet (annual, 2025-12-31) — Accrued Interest Receivable: 127000.00
AMBR balance_sheet (quarterly, 2025-12-31) — Accrued Interest Receivable: 127000.00
AMBR balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -17000.00
AMBR balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -17000.00
AMBR balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 90540000.00
AMBR balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 90540000.00
AMBR balance_sheet (annual, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -1855000.00
AMBR balance_sheet (quarterly, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -1855000.00
AMBR cash_flow (annual, 2025-12-31) — Amortization Cash Flow: 733000.00
AMBR cash_flow (annual, 2025-12-31) — Amortization Of Intangibles: 733000.00
AMBR cash_flow (annual, 2025-12-31) — Asset Impairment Charge: -677000.00
AMBR balance_sheet (annual, 2025-12-31) — Assets Held For Sale Current: 17000.00
AMBR balance_sheet (quarterly, 2025-12-31) — Assets Held For Sale Current: 17000.00
AMBR income_statement (annual, 2025-12-31) — Basic Average Shares: 86636218.00
AMBR income_statement (quarterly, 2025-12-31) — Basic Average Shares: 93762225.00
AMBR income_statement (annual, 2025-12-31) — Basic EPS: 0.04
AMBR income_statement (quarterly, 2025-12-31) — Basic EPS: 0.01
AMBR cash_flow (annual, 2025-12-31) — Beginning Cash Position: 6277000.00
AMBR cash_flow (annual, 2025-12-31) — Capital Expenditure: -376000.00
AMBR balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 1589000.00
AMBR balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 1589000.00
AMBR balance_sheet (annual, 2025-12-31) — Capital Stock: 424000.00
AMBR balance_sheet (quarterly, 2025-12-31) — Capital Stock: 424000.00
AMBR balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 29895000.00
AMBR balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 29895000.00
AMBR balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 52815000.00
AMBR balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 52815000.00
AMBR cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 37297000.00
AMBR cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: 10739000.00
AMBR cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: -24551000.00
AMBR cash_flow (annual, 2025-12-31) — Change In Other Working Capital: 11656000.00
AMBR cash_flow (annual, 2025-12-31) — Change In Payable: -5067000.00
AMBR cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: -5067000.00
AMBR cash_flow (annual, 2025-12-31) — Change In Receivables: 3226000.00
AMBR cash_flow (annual, 2025-12-31) — Change In Working Capital: 9815000.00
AMBR cash_flow (annual, 2025-12-31) — Changes In Cash: 23485000.00
AMBR balance_sheet (annual, 2025-12-31) — Common Stock: 424000.00
AMBR balance_sheet (quarterly, 2025-12-31) — Common Stock: 424000.00
AMBR balance_sheet (annual, 2025-12-31) — Common Stock Equity: 110312000.00
AMBR balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 110312000.00
AMBR cash_flow (annual, 2025-12-31) — Common Stock Issuance: 25339000.00
AMBR cash_flow (annual, 2025-12-31) — Common Stock Payments: -880000.00
AMBR income_statement (annual, 2025-12-31) — Cost Of Revenue: 16653000.00
AMBR income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 4209000.00
AMBR balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 8772000.00
AMBR balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 8772000.00
AMBR balance_sheet (annual, 2025-12-31) — Current Assets: 196932000.00
AMBR balance_sheet (quarterly, 2025-12-31) — Current Assets: 196932000.00
AMBR balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 867000.00
AMBR balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 867000.00
AMBR balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 867000.00
AMBR balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 867000.00
AMBR balance_sheet (annual, 2025-12-31) — Current Deferred Liabilities: 8854000.00
AMBR balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 8854000.00
AMBR balance_sheet (annual, 2025-12-31) — Current Deferred Revenue: 8854000.00
AMBR balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 8854000.00
AMBR balance_sheet (annual, 2025-12-31) — Current Liabilities: 145298000.00
AMBR balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 145298000.00
AMBR cash_flow (annual, 2025-12-31) — Depreciation: 718000.00
AMBR cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 1451000.00
AMBR cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 1451000.00
AMBR income_statement (annual, 2025-12-31) — Diluted Average Shares: 86649319.00
AMBR income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 93775581.00
AMBR income_statement (annual, 2025-12-31) — Diluted EPS: 0.04
AMBR income_statement (quarterly, 2025-12-31) — Diluted EPS: 0.01
AMBR income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 3751000.00
AMBR income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 570000.00
AMBR balance_sheet (annual, 2025-12-31) — Duefrom Related Parties Current: 32341000.00
AMBR balance_sheet (quarterly, 2025-12-31) — Duefrom Related Parties Current: 32341000.00
AMBR balance_sheet (annual, 2025-12-31) — Dueto Related Parties Current: 48031000.00
AMBR balance_sheet (quarterly, 2025-12-31) — Dueto Related Parties Current: 48031000.00
AMBR income_statement (annual, 2025-12-31) — EBIT: 3669000.00
AMBR income_statement (quarterly, 2025-12-31) — EBIT: 2233000.00
AMBR income_statement (annual, 2025-12-31) — EBITDA: 5120000.00
AMBR income_statement (quarterly, 2025-12-31) — EBITDA: 2233000.00
AMBR income_statement (annual, 2025-12-31) — Earnings From Equity Interest: -50000.00
AMBR income_statement (quarterly, 2025-12-31) — Earnings From Equity Interest: -12000.00
AMBR cash_flow (annual, 2025-12-31) — Earnings Losses From Equity Investments: 50000.00
AMBR cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: 133000.00
AMBR cash_flow (annual, 2025-12-31) — End Cash Position: 29895000.00
AMBR balance_sheet (annual, 2025-12-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 1189000.00
AMBR balance_sheet (quarterly, 2025-12-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 1189000.00
AMBR cash_flow (annual, 2025-12-31) — Financing Cash Flow: 37297000.00
AMBR cash_flow (annual, 2025-12-31) — Free Cash Flow: -24927000.00
AMBR cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: -37283000.00
AMBR cash_flow (annual, 2025-12-31) — Gain Loss On Sale Of Business: 253000.00
AMBR income_statement (annual, 2025-12-31) — Gain On Sale Of Security: -639000.00
AMBR balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 53390000.00
AMBR balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 53390000.00
AMBR income_statement (annual, 2025-12-31) — General And Administrative Expense: 28096000.00
AMBR income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 7694000.00
AMBR balance_sheet (annual, 2025-12-31) — Goodwill: 53136000.00
AMBR balance_sheet (quarterly, 2025-12-31) — Goodwill: 53136000.00
AMBR balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 56085000.00
AMBR balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 56085000.00
AMBR balance_sheet (annual, 2025-12-31) — Gross Accounts Receivable: 7345000.00
AMBR balance_sheet (quarterly, 2025-12-31) — Gross Accounts Receivable: 7345000.00
AMBR balance_sheet (annual, 2025-12-31) — Gross PPE: 1598000.00
AMBR balance_sheet (quarterly, 2025-12-31) — Gross PPE: 1598000.00
AMBR income_statement (annual, 2025-12-31) — Gross Profit: 49436000.00
AMBR income_statement (quarterly, 2025-12-31) — Gross Profit: 12128000.00
AMBR balance_sheet (annual, 2025-12-31) — Hedging Assets Current: 316000.00
AMBR balance_sheet (quarterly, 2025-12-31) — Hedging Assets Current: 316000.00
AMBR balance_sheet (annual, 2025-12-31) — Income Tax Payable: 513000.00
AMBR balance_sheet (quarterly, 2025-12-31) — Income Tax Payable: 513000.00
AMBR income_statement (annual, 2025-12-31) — Interest Expense: 71000.00
AMBR income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 71000.00
AMBR income_statement (annual, 2025-12-31) — Interest Income: 619000.00
AMBR income_statement (quarterly, 2025-12-31) — Interest Income: 309000.00
AMBR income_statement (annual, 2025-12-31) — Interest Income Non Operating: 619000.00
AMBR income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 309000.00
AMBR balance_sheet (annual, 2025-12-31) — Interest Payable: 421000.00
AMBR balance_sheet (quarterly, 2025-12-31) — Interest Payable: 421000.00
AMBR cash_flow (annual, 2025-12-31) — Interest Received Cfi: 497000.00
AMBR balance_sheet (annual, 2025-12-31) — Invested Capital: 110312000.00
AMBR balance_sheet (quarterly, 2025-12-31) — Invested Capital: 110312000.00
AMBR cash_flow (annual, 2025-12-31) — Investing Cash Flow: 10739000.00
AMBR balance_sheet (annual, 2025-12-31) — Investmentin Financial Assets: 1189000.00
AMBR balance_sheet (quarterly, 2025-12-31) — Investmentin Financial Assets: 1189000.00
AMBR balance_sheet (annual, 2025-12-31) — Investments And Advances: 1279000.00
AMBR balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 1279000.00
AMBR cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 25339000.00
AMBR cash_flow (annual, 2025-12-31) — Issuance Of Debt: 14250000.00
AMBR balance_sheet (annual, 2025-12-31) — Leases: 0.00
AMBR balance_sheet (quarterly, 2025-12-31) — Leases: 0.00
AMBR balance_sheet (annual, 2025-12-31) — Loans Receivable: 45999000.00
AMBR balance_sheet (quarterly, 2025-12-31) — Loans Receivable: 45999000.00
AMBR balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 722000.00
AMBR balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 722000.00
AMBR balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 722000.00
AMBR balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 722000.00
AMBR cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 14250000.00
AMBR cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -1412000.00
AMBR balance_sheet (annual, 2025-12-31) — Long Term Equity Investment: 90000.00
AMBR balance_sheet (quarterly, 2025-12-31) — Long Term Equity Investment: 90000.00
AMBR balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 114000.00
AMBR balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 114000.00
AMBR balance_sheet (annual, 2025-12-31) — Minority Interest: 0.00
AMBR balance_sheet (quarterly, 2025-12-31) — Minority Interest: 0.00
AMBR income_statement (annual, 2025-12-31) — Minority Interests: 1121000.00
AMBR income_statement (quarterly, 2025-12-31) — Minority Interests: 1121000.00
AMBR cash_flow (annual, 2025-12-31) — Net Business Purchase And Sale: 15283000.00
AMBR cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 24459000.00
AMBR income_statement (annual, 2025-12-31) — Net Income: 3751000.00
AMBR income_statement (quarterly, 2025-12-31) — Net Income: 570000.00
AMBR income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 3751000.00
AMBR income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 570000.00
AMBR income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 4665000.00
AMBR income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 827000.00
AMBR income_statement (annual, 2025-12-31) — Net Income Discontinuous Operations: -2035000.00
AMBR income_statement (quarterly, 2025-12-31) — Net Income Discontinuous Operations: -1378000.00
AMBR income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 3751000.00
AMBR income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 570000.00
AMBR income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 5786000.00
AMBR income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 1948000.00
AMBR cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 1253000.00
AMBR income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 2630000.00
AMBR income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -551000.00
AMBR cash_flow (annual, 2025-12-31) — Net Intangibles Purchase And Sale: -284000.00
AMBR income_statement (annual, 2025-12-31) — Net Interest Income: 548000.00
AMBR income_statement (quarterly, 2025-12-31) — Net Interest Income: 238000.00
AMBR cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: -665000.00
AMBR cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: 12838000.00
AMBR cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: 12838000.00
AMBR income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: 548000.00
AMBR income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: 238000.00
AMBR cash_flow (annual, 2025-12-31) — Net Other Investing Changes: -4000000.00
AMBR balance_sheet (annual, 2025-12-31) — Net PPE: 1581000.00
AMBR balance_sheet (quarterly, 2025-12-31) — Net PPE: 1581000.00
AMBR cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -92000.00
AMBR cash_flow (annual, 2025-12-31) — Net Preferred Stock Issuance: 0.00
AMBR balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 54227000.00
AMBR balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 54227000.00
AMBR balance_sheet (annual, 2025-12-31) — Non Current Accounts Receivable: 495000.00
AMBR balance_sheet (quarterly, 2025-12-31) — Non Current Accounts Receivable: 495000.00
AMBR balance_sheet (annual, 2025-12-31) — Non Current Accrued Expenses: 47000.00
AMBR balance_sheet (quarterly, 2025-12-31) — Non Current Accrued Expenses: 47000.00
AMBR balance_sheet (annual, 2025-12-31) — Non Current Deferred Assets: 7000.00
AMBR balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Assets: 7000.00
AMBR balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Assets: 7000.00
AMBR balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Assets: 7000.00
AMBR income_statement (annual, 2025-12-31) — Normalized EBITDA: 5082000.00
AMBR income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 2233000.00
AMBR income_statement (annual, 2025-12-31) — Normalized Income: 5754460.00
AMBR income_statement (quarterly, 2025-12-31) — Normalized Income: 1948000.00
AMBR cash_flow (annual, 2025-12-31) — Operating Cash Flow: -24551000.00
AMBR cash_flow (annual, 2025-12-31) — Operating Gains Losses: -36980000.00
AMBR income_statement (annual, 2025-12-31) — Operating Income: 2811000.00
AMBR income_statement (quarterly, 2025-12-31) — Operating Income: 1375000.00
AMBR income_statement (annual, 2025-12-31) — Operating Revenue: 66089000.00
AMBR income_statement (quarterly, 2025-12-31) — Operating Revenue: 16337000.00
AMBR balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 471376257.00
AMBR balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 471376257.00
AMBR balance_sheet (annual, 2025-12-31) — Other Current Assets: 45958000.00
AMBR balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 45958000.00
AMBR balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 62523000.00
AMBR balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 62523000.00
AMBR balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: 53390000.00
AMBR balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: 53390000.00
AMBR income_statement (annual, 2025-12-31) — Other Gand A: 28096000.00
AMBR income_statement (quarterly, 2025-12-31) — Other Gand A: 7694000.00
AMBR income_statement (annual, 2025-12-31) — Other Income Expense: 239000.00
AMBR income_statement (quarterly, 2025-12-31) — Other Income Expense: -1844000.00
AMBR balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 2949000.00
AMBR balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 2949000.00
AMBR cash_flow (annual, 2025-12-31) — Other Non Cash Items: -548000.00
AMBR income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: 251000.00
AMBR income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: -1870000.00
AMBR income_statement (annual, 2025-12-31) — Other Operating Expenses: -216000.00
AMBR balance_sheet (annual, 2025-12-31) — Other Payable: 12639000.00
AMBR balance_sheet (quarterly, 2025-12-31) — Other Payable: 12639000.00
AMBR balance_sheet (annual, 2025-12-31) — Other Properties: 1484000.00
AMBR balance_sheet (quarterly, 2025-12-31) — Other Properties: 1484000.00
AMBR balance_sheet (annual, 2025-12-31) — Other Receivables: 602000.00
AMBR balance_sheet (quarterly, 2025-12-31) — Other Receivables: 602000.00
AMBR balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 22920000.00
AMBR balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 22920000.00
AMBR income_statement (annual, 2025-12-31) — Other Special Charges: -677000.00
AMBR balance_sheet (annual, 2025-12-31) — Payables: 64282000.00
AMBR balance_sheet (quarterly, 2025-12-31) — Payables: 64282000.00
AMBR balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 73054000.00
AMBR balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 73054000.00
AMBR cash_flow (annual, 2025-12-31) — Preferred Stock Issuance: 0.00
AMBR balance_sheet (annual, 2025-12-31) — Prepaid Assets: 6447000.00
AMBR balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 6447000.00
AMBR income_statement (annual, 2025-12-31) — Pretax Income: 3598000.00
AMBR income_statement (quarterly, 2025-12-31) — Pretax Income: -231000.00
AMBR balance_sheet (annual, 2025-12-31) — Properties: 0.00
AMBR balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
AMBR cash_flow (annual, 2025-12-31) — Provisionand Write Offof Assets: -1431000.00
AMBR cash_flow (annual, 2025-12-31) — Purchase Of Business: -2558000.00
AMBR cash_flow (annual, 2025-12-31) — Purchase Of Intangibles: -284000.00
AMBR cash_flow (annual, 2025-12-31) — Purchase Of PPE: -92000.00
AMBR balance_sheet (annual, 2025-12-31) — Receivables: 84801000.00
AMBR balance_sheet (quarterly, 2025-12-31) — Receivables: 84801000.00
AMBR income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 16653000.00
AMBR income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 4209000.00
AMBR income_statement (annual, 2025-12-31) — Reconciled Depreciation: 1451000.00
AMBR cash_flow (annual, 2025-12-31) — Repayment Of Debt: -1412000.00
AMBR cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -880000.00
AMBR income_statement (annual, 2025-12-31) — Research And Development: 10812000.00
AMBR income_statement (quarterly, 2025-12-31) — Research And Development: 1201000.00
AMBR balance_sheet (annual, 2025-12-31) — Restricted Cash: 6578000.00
AMBR balance_sheet (quarterly, 2025-12-31) — Restricted Cash: 6578000.00
AMBR balance_sheet (annual, 2025-12-31) — Retained Earnings: -33139000.00
AMBR balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -33139000.00
AMBR cash_flow (annual, 2025-12-31) — Sale Of Business: 17841000.00
AMBR income_statement (annual, 2025-12-31) — Selling And Marketing Expense: 7933000.00
AMBR income_statement (quarterly, 2025-12-31) — Selling And Marketing Expense: 2074000.00
AMBR income_statement (annual, 2025-12-31) — Selling General And Administration: 36029000.00
AMBR income_statement (quarterly, 2025-12-31) — Selling General And Administration: 9768000.00
AMBR balance_sheet (annual, 2025-12-31) — Share Issued: 473959772.00
AMBR balance_sheet (quarterly, 2025-12-31) — Share Issued: 473959772.00
AMBR income_statement (annual, 2025-12-31) — Special Income Charges: 677000.00
AMBR cash_flow (annual, 2025-12-31) — Stock Based Compensation: 591000.00
AMBR balance_sheet (annual, 2025-12-31) — Stockholders Equity: 110312000.00
AMBR balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 110312000.00
AMBR balance_sheet (annual, 2025-12-31) — Tangible Book Value: 54227000.00
AMBR balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 54227000.00
AMBR income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 6460.00
AMBR income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
AMBR income_statement (annual, 2025-12-31) — Tax Provision: -1067000.00
AMBR income_statement (quarterly, 2025-12-31) — Tax Provision: -1058000.00
AMBR income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.17
AMBR income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.17
AMBR balance_sheet (annual, 2025-12-31) — Taxes Receivable: 242000.00
AMBR balance_sheet (quarterly, 2025-12-31) — Taxes Receivable: 242000.00
AMBR cash_flow (annual, 2025-12-31) — Taxes Refund Paid: 336000.00
AMBR balance_sheet (annual, 2025-12-31) — Total Assets: 256379000.00
AMBR balance_sheet (quarterly, 2025-12-31) — Total Assets: 256379000.00
AMBR balance_sheet (annual, 2025-12-31) — Total Capitalization: 110312000.00
AMBR balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 110312000.00
AMBR balance_sheet (annual, 2025-12-31) — Total Debt: 1589000.00
AMBR balance_sheet (quarterly, 2025-12-31) — Total Debt: 1589000.00
AMBR balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 110312000.00
AMBR balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 110312000.00
AMBR income_statement (annual, 2025-12-31) — Total Expenses: 63278000.00
AMBR income_statement (quarterly, 2025-12-31) — Total Expenses: 14962000.00
AMBR balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 146067000.00
AMBR balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 146067000.00
AMBR balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 59447000.00
AMBR balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 59447000.00
AMBR balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 769000.00
AMBR balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 769000.00
AMBR income_statement (annual, 2025-12-31) — Total Operating Income As Reported: 2595000.00
AMBR income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: 1159000.00
AMBR balance_sheet (annual, 2025-12-31) — Total Tax Payable: 532000.00
AMBR balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 532000.00
AMBR income_statement (annual, 2025-12-31) — Total Unusual Items: 38000.00
AMBR income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: 38000.00
AMBR balance_sheet (annual, 2025-12-31) — Treasury Shares Number: 2583515.00
AMBR balance_sheet (quarterly, 2025-12-31) — Treasury Shares Number: 2583515.00
AMBR balance_sheet (annual, 2025-12-31) — Treasury Stock: 903000.00
AMBR balance_sheet (quarterly, 2025-12-31) — Treasury Stock: 903000.00
AMBR cash_flow (annual, 2025-12-31) — Unrealized Gain Loss On Investment Securities: 1639000.00
AMBR balance_sheet (annual, 2025-12-31) — Working Capital: 51634000.00
AMBR balance_sheet (quarterly, 2025-12-31) — Working Capital: 51634000.00
AMBR income_statement (quarterly, 2026-03-31) — +Operating Expense: 9980000.00
AMBR income_statement (quarterly, 2026-03-31) — +Total Revenue: 10028000.00
AMBR balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 11092000.00
AMBR balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 12994000.00
AMBR balance_sheet (quarterly, 2026-03-31) — Assets Held For Sale Current: 13000.00
AMBR income_statement (quarterly, 2026-03-31) — Basic Average Shares: 93837525.00
AMBR income_statement (quarterly, 2026-03-31) — Basic EPS: -0.04
AMBR balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 1341000.00
AMBR balance_sheet (quarterly, 2026-03-31) — Capital Stock: 86481000.00
AMBR balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 36482000.00
AMBR balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 54428000.00
AMBR balance_sheet (quarterly, 2026-03-31) — Common Stock: 86481000.00
AMBR balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 102596000.00
AMBR income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 3240000.00
AMBR balance_sheet (quarterly, 2026-03-31) — Current Assets: 176248000.00
AMBR balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 857000.00
AMBR balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 857000.00
AMBR balance_sheet (quarterly, 2026-03-31) — Current Deferred Liabilities: 8555000.00
AMBR balance_sheet (quarterly, 2026-03-31) — Current Deferred Revenue: 8555000.00
AMBR balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 132484000.00
AMBR income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 93837525.00
AMBR income_statement (quarterly, 2026-03-31) — Diluted EPS: -0.04
AMBR income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -3732000.00
AMBR balance_sheet (quarterly, 2026-03-31) — Duefrom Related Parties Current: 48634000.00
AMBR balance_sheet (quarterly, 2026-03-31) — Dueto Related Parties Current: 44649000.00
AMBR income_statement (quarterly, 2026-03-31) — EBIT: -3192000.00
AMBR income_statement (quarterly, 2026-03-31) — EBITDA: -3192000.00
AMBR income_statement (quarterly, 2026-03-31) — Earnings From Equity Interest: -11000.00
AMBR balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: 52986000.00
AMBR income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 6150000.00
AMBR balance_sheet (quarterly, 2026-03-31) — Goodwill: 53136000.00
AMBR balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 55942000.00
AMBR income_statement (quarterly, 2026-03-31) — Gross Profit: 6788000.00
AMBR balance_sheet (quarterly, 2026-03-31) — Hedging Assets Current: 25000.00
AMBR balance_sheet (quarterly, 2026-03-31) — Income Tax Payable: 512000.00
AMBR income_statement (quarterly, 2026-03-31) — Interest Income: 96000.00
AMBR income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 96000.00
AMBR balance_sheet (quarterly, 2026-03-31) — Invested Capital: 102596000.00
AMBR balance_sheet (quarterly, 2026-03-31) — Loans Receivable: 30205000.00
AMBR balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 484000.00
AMBR balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 484000.00
AMBR income_statement (quarterly, 2026-03-31) — Minority Interests: 0.00
AMBR income_statement (quarterly, 2026-03-31) — Net Income: -3732000.00
AMBR income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -3732000.00
AMBR income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -3728000.00
AMBR income_statement (quarterly, 2026-03-31) — Net Income Discontinuous Operations: -4000.00
AMBR income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -3732000.00
AMBR income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -3728000.00
AMBR income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -3732000.00
AMBR income_statement (quarterly, 2026-03-31) — Net Interest Income: 96000.00
AMBR income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: 96000.00
AMBR balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 46654000.00
AMBR income_statement (quarterly, 2026-03-31) — Normalized EBITDA: -3192000.00
AMBR income_statement (quarterly, 2026-03-31) — Normalized Income: -3728000.00
AMBR income_statement (quarterly, 2026-03-31) — Operating Income: -3192000.00
AMBR income_statement (quarterly, 2026-03-31) — Operating Revenue: 10028000.00
AMBR balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 471376257.00
AMBR balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 27517000.00
AMBR balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 52485000.00
AMBR income_statement (quarterly, 2026-03-31) — Other Gand A: 6150000.00
AMBR income_statement (quarterly, 2026-03-31) — Other Income Expense: -626000.00
AMBR balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 2806000.00
AMBR balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 3421000.00
AMBR balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 47000.00
AMBR income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: -615000.00
AMBR balance_sheet (quarterly, 2026-03-31) — Other Payable: 14334000.00
AMBR balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 17946000.00
AMBR balance_sheet (quarterly, 2026-03-31) — Payables: 70587000.00
AMBR balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 70587000.00
AMBR income_statement (quarterly, 2026-03-31) — Pretax Income: -3722000.00
AMBR balance_sheet (quarterly, 2026-03-31) — Receivables: 91967000.00
AMBR income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 3240000.00
AMBR income_statement (quarterly, 2026-03-31) — Research And Development: 1541000.00
AMBR balance_sheet (quarterly, 2026-03-31) — Restricted Cash: 2298000.00
AMBR balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -36871000.00
AMBR income_statement (quarterly, 2026-03-31) — Selling And Marketing Expense: 2289000.00
AMBR income_statement (quarterly, 2026-03-31) — Selling General And Administration: 8439000.00
AMBR balance_sheet (quarterly, 2026-03-31) — Share Issued: 473959772.00
AMBR balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 102596000.00
AMBR balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 46654000.00
AMBR income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
AMBR income_statement (quarterly, 2026-03-31) — Tax Provision: 6000.00
AMBR income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.40
AMBR balance_sheet (quarterly, 2026-03-31) — Taxes Receivable: 134000.00
AMBR balance_sheet (quarterly, 2026-03-31) — Total Assets: 235611000.00
AMBR balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 102596000.00
AMBR balance_sheet (quarterly, 2026-03-31) — Total Debt: 1341000.00
AMBR balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 102596000.00
AMBR income_statement (quarterly, 2026-03-31) — Total Expenses: 13220000.00
AMBR balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 133015000.00
AMBR balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 59363000.00
AMBR balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 531000.00
AMBR income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: -3192000.00
AMBR balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 512000.00
AMBR balance_sheet (quarterly, 2026-03-31) — Treasury Shares Number: 2583515.00
AMBR balance_sheet (quarterly, 2026-03-31) — Working Capital: 43764000.00
AMBUJACEM.NS balance_sheet (annual, 2021-12-31) — Accounts Payable: 29128200000.00
AMBUJACEM.NS balance_sheet (annual, 2021-12-31) — Accounts Receivable: 6190700000.00
AMBUJACEM.NS balance_sheet (annual, 2021-12-31) — Accumulated Depreciation: -69512800000.00
AMBUJACEM.NS balance_sheet (annual, 2021-12-31) — Additional Paid In Capital: 124810900000.00
AMBUJACEM.NS balance_sheet (annual, 2021-12-31) — Allowance For Doubtful Accounts Receivable: -764100000.00
AMBUJACEM.NS income_statement (annual, 2021-12-31) — Amortization: 165000000.00
AMBUJACEM.NS balance_sheet (annual, 2021-12-31) — Assets Held For Sale Current: 254400000.00
AMBUJACEM.NS balance_sheet (annual, 2021-12-31) — Available For Sale Securities: 847100000.00
AMBUJACEM.NS income_statement (annual, 2021-12-31) — Basic Average Shares: 1985645229.00
AMBUJACEM.NS income_statement (annual, 2021-12-31) — Basic EPS: 14.00
AMBUJACEM.NS balance_sheet (annual, 2021-12-31) — Buildings And Improvements: 36332400000.00
AMBUJACEM.NS balance_sheet (annual, 2021-12-31) — Capital Lease Obligations: 4296300000.00
AMBUJACEM.NS balance_sheet (annual, 2021-12-31) — Capital Stock: 3971300000.00
AMBUJACEM.NS balance_sheet (annual, 2021-12-31) — Cash And Cash Equivalents: 113584900000.00
AMBUJACEM.NS balance_sheet (annual, 2021-12-31) — Cash Cash Equivalents And Short Term Investments: 113769900000.00
AMBUJACEM.NS balance_sheet (annual, 2021-12-31) — Cash Equivalents: 111498800000.00
AMBUJACEM.NS balance_sheet (annual, 2021-12-31) — Cash Financial: 2086100000.00
AMBUJACEM.NS cash_flow (annual, 2021-12-31) — Change In Other Current Assets: -1860400000.00
AMBUJACEM.NS cash_flow (annual, 2021-12-31) — Change In Other Current Liabilities: 3960700000.00
AMBUJACEM.NS balance_sheet (annual, 2021-12-31) — Common Stock: 3971300000.00
AMBUJACEM.NS cash_flow (annual, 2021-12-31) — Common Stock Dividend Paid: -2021000000.00
AMBUJACEM.NS balance_sheet (annual, 2021-12-31) — Common Stock Equity: 253537400000.00
AMBUJACEM.NS balance_sheet (annual, 2021-12-31) — Construction In Progress: 21677300000.00
AMBUJACEM.NS balance_sheet (annual, 2021-12-31) — Current Assets: 170184200000.00
AMBUJACEM.NS balance_sheet (annual, 2021-12-31) — Current Capital Lease Obligation: 671100000.00
AMBUJACEM.NS balance_sheet (annual, 2021-12-31) — Current Debt: 34400000.00
AMBUJACEM.NS balance_sheet (annual, 2021-12-31) — Current Debt And Capital Lease Obligation: 705500000.00
AMBUJACEM.NS balance_sheet (annual, 2021-12-31) — Current Liabilities: 112252000000.00
AMBUJACEM.NS balance_sheet (annual, 2021-12-31) — Current Provisions: 246400000.00
AMBUJACEM.NS income_statement (annual, 2021-12-31) — Diluted Average Shares: 1985960632.00
AMBUJACEM.NS income_statement (annual, 2021-12-31) — Diluted EPS: 14.00
AMBUJACEM.NS balance_sheet (annual, 2021-12-31) — Dividends Payable: 500500000.00
AMBUJACEM.NS balance_sheet (annual, 2021-12-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 239000000.00
AMBUJACEM.NS balance_sheet (annual, 2021-12-31) — Finished Goods: 2569100000.00
AMBUJACEM.NS cash_flow (annual, 2021-12-31) — Gain Loss On Sale Of Business: 0.00
AMBUJACEM.NS income_statement (annual, 2021-12-31) — General And Administrative Expense: 774100000.00
AMBUJACEM.NS balance_sheet (annual, 2021-12-31) — Goodwill: 78696900000.00
AMBUJACEM.NS balance_sheet (annual, 2021-12-31) — Goodwill And Other Intangible Assets: 80938000000.00
AMBUJACEM.NS balance_sheet (annual, 2021-12-31) — Gross Accounts Receivable: 6954800000.00
AMBUJACEM.NS balance_sheet (annual, 2021-12-31) — Gross PPE: 232787700000.00
AMBUJACEM.NS balance_sheet (annual, 2021-12-31) — Held To Maturity Securities: 37000000.00
AMBUJACEM.NS income_statement (annual, 2021-12-31) — Interest Income: 3336200000.00
AMBUJACEM.NS income_statement (annual, 2021-12-31) — Interest Income Non Operating: 3336200000.00
AMBUJACEM.NS balance_sheet (annual, 2021-12-31) — Inventory: 27380400000.00
AMBUJACEM.NS balance_sheet (annual, 2021-12-31) — Invested Capital: 254006800000.00
AMBUJACEM.NS balance_sheet (annual, 2021-12-31) — Investmentin Financial Assets: 1086100000.00
AMBUJACEM.NS balance_sheet (annual, 2021-12-31) — Investmentsin Associatesat Cost: 1207200000.00
AMBUJACEM.NS balance_sheet (annual, 2021-12-31) — Investmentsin Joint Venturesat Cost: 497900000.00
AMBUJACEM.NS cash_flow (annual, 2021-12-31) — Issuance Of Debt: 0.00
AMBUJACEM.NS balance_sheet (annual, 2021-12-31) — Land And Improvements: 22157900000.00
AMBUJACEM.NS balance_sheet (annual, 2021-12-31) — Long Term Capital Lease Obligation: 3625200000.00
AMBUJACEM.NS balance_sheet (annual, 2021-12-31) — Long Term Debt: 435000000.00
AMBUJACEM.NS balance_sheet (annual, 2021-12-31) — Long Term Debt And Capital Lease Obligation: 4060200000.00
AMBUJACEM.NS cash_flow (annual, 2021-12-31) — Long Term Debt Issuance: 0.00
AMBUJACEM.NS balance_sheet (annual, 2021-12-31) — Long Term Equity Investment: 1705100000.00
AMBUJACEM.NS balance_sheet (annual, 2021-12-31) — Long Term Provisions: 2815400000.00
AMBUJACEM.NS balance_sheet (annual, 2021-12-31) — Machinery Furniture Equipment: 151695500000.00
AMBUJACEM.NS balance_sheet (annual, 2021-12-31) — Minority Interest: 71450300000.00
AMBUJACEM.NS cash_flow (annual, 2021-12-31) — Net Business Purchase And Sale: 0.00
AMBUJACEM.NS cash_flow (annual, 2021-12-31) — Net Foreign Currency Exchange Gain Loss: 33600000.00
AMBUJACEM.NS cash_flow (annual, 2021-12-31) — Net Other Financing Charges: 35400000.00
AMBUJACEM.NS cash_flow (annual, 2021-12-31) — Net Other Investing Changes: -200000.00
AMBUJACEM.NS balance_sheet (annual, 2021-12-31) — Net PPE: 163274900000.00
AMBUJACEM.NS balance_sheet (annual, 2021-12-31) — Net Tangible Assets: 172599400000.00
AMBUJACEM.NS balance_sheet (annual, 2021-12-31) — Non Current Deferred Taxes Assets: 29100000.00
AMBUJACEM.NS balance_sheet (annual, 2021-12-31) — Non Current Deferred Taxes Liabilities: 7561900000.00
AMBUJACEM.NS balance_sheet (annual, 2021-12-31) — Non Current Prepaid Assets: 11560300000.00
AMBUJACEM.NS balance_sheet (annual, 2021-12-31) — Ordinary Shares Number: 1985645229.00
AMBUJACEM.NS cash_flow (annual, 2021-12-31) — Other Cash Adjustment Outside Changein Cash: 5800000.00
AMBUJACEM.NS balance_sheet (annual, 2021-12-31) — Other Current Assets: 232500000.00
AMBUJACEM.NS balance_sheet (annual, 2021-12-31) — Other Current Liabilities: 10070500000.00
AMBUJACEM.NS balance_sheet (annual, 2021-12-31) — Other Equity Interest: 141200000.00
AMBUJACEM.NS balance_sheet (annual, 2021-12-31) — Other Intangible Assets: 2241100000.00
AMBUJACEM.NS balance_sheet (annual, 2021-12-31) — Other Inventories: 10465300000.00
AMBUJACEM.NS balance_sheet (annual, 2021-12-31) — Other Non Current Assets: 9579500000.00
AMBUJACEM.NS balance_sheet (annual, 2021-12-31) — Other Non Current Liabilities: 367400000.00
AMBUJACEM.NS balance_sheet (annual, 2021-12-31) — Other Payable: 33118200000.00
AMBUJACEM.NS balance_sheet (annual, 2021-12-31) — Other Properties: 924600000.00
AMBUJACEM.NS balance_sheet (annual, 2021-12-31) — Other Receivables: 4346800000.00
AMBUJACEM.NS balance_sheet (annual, 2021-12-31) — Other Short Term Investments: 185000000.00
AMBUJACEM.NS balance_sheet (annual, 2021-12-31) — Payables: 81805900000.00
AMBUJACEM.NS balance_sheet (annual, 2021-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 246400000.00
AMBUJACEM.NS balance_sheet (annual, 2021-12-31) — Prepaid Assets: 14664600000.00
AMBUJACEM.NS balance_sheet (annual, 2021-12-31) — Properties: 0.00
AMBUJACEM.NS cash_flow (annual, 2021-12-31) — Provisionand Write Offof Assets: 111900000.00
AMBUJACEM.NS cash_flow (annual, 2021-12-31) — Purchase Of Investment: -149000000.00
AMBUJACEM.NS balance_sheet (annual, 2021-12-31) — Raw Materials: 6498700000.00
AMBUJACEM.NS income_statement (annual, 2021-12-31) — Rent And Landing Fees: 1695800000.00
AMBUJACEM.NS income_statement (annual, 2021-12-31) — Rent Expense Supplemental: 1695800000.00
AMBUJACEM.NS balance_sheet (annual, 2021-12-31) — Restricted Cash: 3344900000.00
AMBUJACEM.NS income_statement (annual, 2021-12-31) — Restructuring And Mergern Acquisition: 1204500000.00
AMBUJACEM.NS balance_sheet (annual, 2021-12-31) — Retained Earnings: 65162000000.00
AMBUJACEM.NS cash_flow (annual, 2021-12-31) — Sale Of Business: 0.00
AMBUJACEM.NS cash_flow (annual, 2021-12-31) — Sale Of Investment: 215900000.00
AMBUJACEM.NS balance_sheet (annual, 2021-12-31) — Share Issued: 1985645229.00
AMBUJACEM.NS cash_flow (annual, 2021-12-31) — Stock Based Compensation: 80100000.00
AMBUJACEM.NS balance_sheet (annual, 2021-12-31) — Stockholders Equity: 253537400000.00
AMBUJACEM.NS balance_sheet (annual, 2021-12-31) — Tangible Book Value: 172599400000.00
AMBUJACEM.NS balance_sheet (annual, 2021-12-31) — Total Assets: 452045900000.00
AMBUJACEM.NS balance_sheet (annual, 2021-12-31) — Total Capitalization: 253972400000.00
AMBUJACEM.NS balance_sheet (annual, 2021-12-31) — Total Debt: 4765700000.00
AMBUJACEM.NS balance_sheet (annual, 2021-12-31) — Total Equity Gross Minority Interest: 324987700000.00
AMBUJACEM.NS balance_sheet (annual, 2021-12-31) — Total Liabilities Net Minority Interest: 127058200000.00
AMBUJACEM.NS balance_sheet (annual, 2021-12-31) — Total Non Current Assets: 281861700000.00
AMBUJACEM.NS balance_sheet (annual, 2021-12-31) — Total Non Current Liabilities Net Minority Interest: 14806200000.00